Atrasentan Structural Formula (Vanrafia 01)
Vanrafia Tablet, Film Coated
Product Images NDC 0078-1420
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Vanrafia (NDC 0078-1420). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1: Geometric Mean Percent Change From Baseline In Upcr By Visit In Align (Vanrafia 02)
Principal Display Panel Ndc 0078-1420-15 Rx Only Vanrafia™ (atrasentan) Tablets 0.75 mg Dispense With Accompanying Medication Guide. Swallow Tablets Whole. Do Not Cut, Crush, Or Chew. 30 Tablets Novartis (Vanrafia 03)
This text provides information about a medication called VANRAFIA™ in tablet form with a dosage of 0.75mg. It instructs to dispense it with the accompanying Medication Guide and to take the tablet whole without cutting or crushing it. There are 30 tablets in the pack. The recommended dosage and storage conditions are also provided. The product belongs to Novartis and includes a Global Trade Item Number (GTIN).*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
